These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29046738)

  • 1. Colorectal cancer incidence in
    Seppälä T; Pylvänäinen K; Evans DG; Järvinen H; Renkonen-Sinisalo L; Bernstein I; Holinski-Feder E; Sala P; Lindblom A; Macrae F; Blanco I; Sijmons R; Jeffries J; Vasen H; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen J; Jenkins M; Genuardi M; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Frayling IM; Plazzer JP; Sampson JR; Capella G; Möslein G; Mecklin JP; Møller P;
    Hered Cancer Clin Pract; 2017; 15():18. PubMed ID: 29046738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.
    Seppälä TT; Ahadova A; Dominguez-Valentin M; Macrae F; Evans DG; Therkildsen C; Sampson J; Scott R; Burn J; Möslein G; Bernstein I; Holinski-Feder E; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Lautrup CK; Lindblom A; Plazzer JP; Winship I; Tjandra D; Katz LH; Aretz S; Hüneburg R; Holzapfel S; Heinimann K; Valle AD; Neffa F; Gluck N; de Vos Tot Nederveen Cappel WH; Vasen H; Morak M; Steinke-Lange V; Engel C; Rahner N; Schmiegel W; Vangala D; Thomas H; Green K; Lalloo F; Crosbie EJ; Hill J; Capella G; Pineda M; Navarro M; Blanco I; Ten Broeke S; Nielsen M; Ljungmann K; Nakken S; Lindor N; Frayling I; Hovig E; Sunde L; Kloor M; Mecklin JP; Kalager M; Møller P
    Hered Cancer Clin Pract; 2019; 17():8. PubMed ID: 30858900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium.
    Møller P; Seppälä T; Dowty JG; Haupt S; Dominguez-Valentin M; Sunde L; Bernstein I; Engel C; Aretz S; Nielsen M; Capella G; Evans DG; Burn J; Holinski-Feder E; Bertario L; Bonanni B; Lindblom A; Levi Z; Macrae F; Winship I; Plazzer JP; Sijmons R; Laghi L; Valle AD; Heinimann K; Half E; Lopez-Koestner F; Alvarez-Valenzuela K; Scott RJ; Katz L; Laish I; Vainer E; Vaccaro CA; Carraro DM; Gluck N; Abu-Freha N; Stakelum A; Kennelly R; Winter D; Rossi BM; Greenblatt M; Bohorquez M; Sheth H; Tibiletti MG; Lino-Silva LS; Horisberger K; Portenkirchner C; Nascimento I; Rossi NT; da Silva LA; Thomas H; Zaránd A; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepisto A; Peltomäki P; Therkildsen C; Lindberg LJ; Thorlacius-Ussing O; von Knebel Doeberitz M; Loeffler M; Rahner N; Steinke-Lange V; Schmiegel W; Vangala D; Perne C; Hüneburg R; de Vargas AF; Latchford A; Gerdes AM; Backman AS; Guillén-Ponce C; Snyder C; Lautrup CK; Amor D; Palmero E; Stoffel E; Duijkers F; Hall MJ; Hampel H; Williams H; Okkels H; Lubiński J; Reece J; Ngeow J; Guillem JG; Arnold J; Wadt K; Monahan K; Senter L; Rasmussen LJ; van Hest LP; Ricciardiello L; Kohonen-Corish MRJ; Ligtenberg MJL; Southey M; Aronson M; Zahary MN; Samadder NJ; Poplawski N; Hoogerbrugge N; Morrison PJ; James P; Lee G; Chen-Shtoyerman R; Ankathil R; Pai R; Ward R; Parry S; Dębniak T; John T; van Overeem Hansen T; Caldés T; Yamaguchi T; Barca-Tierno V; Garre P; Cavestro GM; Weitz J; Redler S; Büttner R; Heuveline V; Hopper JL; Win AK; Lindor N; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo J; Buchanan DD; Thibodeau SN; Ten Broeke SW; Hovig E; Nakken S; Pineda M; Dueñas N; Brunet J; Green K; Lalloo F; Newton K; Crosbie EJ; Mints M; Tjandra D; Neffa F; Esperon P; Kariv R; Rosner G; Pavicic WH; Kalfayan P; Torrezan GT; Bassaneze T; Martin C; Moslein G; Ahadova A; Kloor M; Sampson JR; Jenkins MA;
    Hered Cancer Clin Pract; 2022 Oct; 20(1):36. PubMed ID: 36182917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
    Engel C; Vasen HF; Seppälä T; Aretz S; Bigirwamungu-Bargeman M; de Boer SY; Bucksch K; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Järvinen H; Kloor M; von Knebel Doeberitz M; Koornstra JJ; van Kouwen M; Langers AM; van de Meeberg PC; Morak M; Möslein G; Nagengast FM; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Sanduleanu S; Schackert HK; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vecht J; Verhulst ML; de Vos Tot Nederveen Cappel W; Zachariae S; Mecklin JP; Loeffler M;
    Gastroenterology; 2018 Nov; 155(5):1400-1409.e2. PubMed ID: 30063918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidences of colorectal adenomas and cancers under colonoscopy surveillance suggest an accelerated "Big Bang" pathway to CRC in three of the four Lynch syndromes.
    Møller P; Haupt S; Ahadova A; Kloor M; Sampson JR; Sunde L; Seppälä T; Burn J; Bernstein I; Capella G; Evans DG; Lindblom A; Winship I; Macrae F; Katz L; Laish I; Vainer E; Monahan K; Half E; Horisberger K; da Silva LA; Heuveline V; Therkildsen C; Lautrup C; Klarskov LL; Cavestro GM; Möslein G; Hovig E; Dominguez-Valentin M
    Hered Cancer Clin Pract; 2024 May; 22(1):6. PubMed ID: 38741120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report.
    Dominguez-Valentin M; Seppälä TT; Sampson JR; Macrae F; Winship I; Evans DG; Scott RJ; Burn J; Möslein G; Bernstein I; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Lindblom A; Plazzer JP; Tjandra D; Thomas H; Green K; Lalloo F; Crosbie EJ; Hill J; Capella G; Pineda M; Navarro M; Vidal JB; Rønlund K; Nielsen RT; Yilmaz M; Elvang LL; Katz L; Nielsen M; Ten Broeke SW; Nakken S; Hovig E; Sunde L; Kloor M; Knebel Doeberitz MV; Ahadova A; Lindor N; Steinke-Lange V; Holinski-Feder E; Mecklin JP; Møller P
    Hered Cancer Clin Pract; 2019; 17():28. PubMed ID: 31636762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incident colorectal cancer in Lynch syndrome is usually not preceded by compromised quality of colonoscopy.
    Lappalainen J; Holmström D; Lepistö A; Saarnio J; Mecklin JP; Seppälä T
    Scand J Gastroenterol; 2019 Dec; 54(12):1473-1480. PubMed ID: 31829749
    [No Abstract]   [Full Text] [Related]  

  • 8. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database.
    Dominguez-Valentin M; Haupt S; Seppälä TT; Sampson JR; Sunde L; Bernstein I; Jenkins MA; Engel C; Aretz S; Nielsen M; Capella G; Balaguer F; Evans DG; Burn J; Holinski-Feder E; Bertario L; Bonanni B; Lindblom A; Levi Z; Macrae F; Winship I; Plazzer JP; Sijmons R; Laghi L; Della Valle A; Heinimann K; Dębniak T; Fruscio R; Lopez-Koestner F; Alvarez-Valenzuela K; Katz LH; Laish I; Vainer E; Vaccaro C; Carraro DM; Monahan K; Half E; Stakelum A; Winter D; Kennelly R; Gluck N; Sheth H; Abu-Freha N; Greenblatt M; Rossi BM; Bohorquez M; Cavestro GM; Lino-Silva LS; Horisberger K; Tibiletti MG; Nascimento ID; Thomas H; Rossi NT; Apolinário da Silva L; Zaránd A; Ruiz-Bañobre J; Heuveline V; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Peltomäki P; Therkildsen C; Madsen MG; Burgdorf SK; Hopper JL; Win AK; Haile RW; Lindor N; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo J; Buchanan DD; Thibodeau SN; von Knebel Doeberitz M; Loeffler M; Rahner N; Schröck E; Steinke-Lange V; Schmiegel W; Vangala D; Perne C; Hüneburg R; Redler S; Büttner R; Weitz J; Pineda M; Duenas N; Vidal JB; Moreira L; Sánchez A; Hovig E; Nakken S; Green K; Lalloo F; Hill J; Crosbie E; Mints M; Goldberg Y; Tjandra D; Ten Broeke SW; Kariv R; Rosner G; Advani SH; Thomas L; Shah P; Shah M; Neffa F; Esperon P; Pavicic W; Torrezan GT; Bassaneze T; Martin CA; Moslein G; Moller P
    EClinicalMedicine; 2023 Apr; 58():101909. PubMed ID: 37181409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?
    Anyla M; Lefevre JH; Creavin B; Colas C; Svrcek M; Lascols O; Debove C; Chafai N; Tiret E; Parc Y
    Int J Colorectal Dis; 2018 Jun; 33(6):703-708. PubMed ID: 29532206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in
    Dominguez-Valentin M; Plazzer JP; Sampson JR; Engel C; Aretz S; Jenkins MA; Sunde L; Bernstein I; Capella G; Balaguer F; Macrae F; Winship IM; Thomas H; Evans DG; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Sijmons RH; Nielsen M; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Lindblom A; Valle AD; Lopez-Kostner F; Alvarez K; Gluck N; Katz L; Heinimann K; Vaccaro CA; Nakken S; Hovig E; Green K; Lalloo F; Hill J; Vasen HFA; Perne C; Büttner R; Görgens H; Holinski-Feder E; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Rahner N; Weitz J; Steinke-Lange V; Schmiegel W; Vangala D; Crosbie EJ; Pineda M; Navarro M; Brunet J; Moreira L; Sánchez A; Serra-Burriel M; Mints M; Kariv R; Rosner G; Piñero TA; Pavicic WH; Kalfayan P; Broeke SWT; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Peltomäki P; Hopper JL; Win AK; Buchanan DD; Lindor NM; Gallinger S; Marchand LL; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Hansen TVO; Lindberg L; Rødland EA; Neffa F; Esperon P; Tjandra D; Möslein G; Seppälä TT; Møller P
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34203177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
    Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
    Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal surveillance outcomes from an institutional longitudinal cohort of lynch syndrome carriers.
    Del Carmen G; Reyes-Uribe L; Goyco D; Evans K; Bowen CM; Kinnison JL; Sepeda VO; Weber DM; Moskowitz J; Mork ME; Thirumurthi S; Lynch PM; Rodriguez-Bigas MA; Taggart MW; You YN; Vilar E
    Front Oncol; 2023; 13():1146825. PubMed ID: 37168379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic surveillance of Lynch syndrome at a highly specialized center in Sweden: An observational study of interval colorectal cancer and individual risk factors.
    Jamizadeh N; Walton Bernstedt S; Haxhijaj A; Andreasson A; Björk J; Forsberg A; Backman AS
    Front Oncol; 2023; 13():1127707. PubMed ID: 36890827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
    Kim TJ; Kim ER; Hong SN; Kim YH; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Kim K; Kim K; Chang DK
    Ann Surg Oncol; 2017 Apr; 24(4):1085-1092. PubMed ID: 27766559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum and Frequency of Tumors, Cancer Risk and Survival in Chilean Families with Lynch Syndrome: Experience of the Implementation of a Registry.
    Álvarez K; Orellana P; De la Fuente M; Canales T; Pinto E; Heine C; Solar B; Hurtado C; Møller P; Kronberg U; Zarate AJ; Dominguez-Valentin M; López-Köstner F
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32549215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of 24 years national surveillance in different hereditary colorectal cancer subgroups leading to more individualised surveillance.
    Lindberg LJ; Ladelund S; Frederiksen BL; Smith-Hansen L; Bernstein I
    J Med Genet; 2017 May; 54(5):297-304. PubMed ID: 28039328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
    Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
    Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality colonoscopy and risk of interval cancer in Lynch syndrome.
    Haanstra JF; Vasen HF; Sanduleanu S; van der Wouden EJ; Koornstra JJ; Kleibeuker JH; de Vos Tot Nederveen Cappel WH
    Int J Colorectal Dis; 2013 Dec; 28(12):1643-9. PubMed ID: 23857598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.